MedPath

Effect of Virtual Reality for Pain Management During Intracervical Balloon Placement for Artificial Childbirth Induction

Not Applicable
Completed
Conditions
Labor Pain
Delivery Problem
Registration Number
NCT05155826
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Brief Summary

The labor induction concerns 22% of births in France. In the event of labor induction, in almost two thirds of cases, a cervical ripening method is used and the use of mechanical methods is observed for 8% of cervical ripening. Intra-cervical balloon placement is generally well tolerated but is frequently associated with pain and acute anxiety. There are few options for pain relief. Virtual reality, a relatively new intervention, has been studied as a distraction technique for pain relief, but never in the context of the induction of childbirth.

Detailed Description

It's prospective single-center, randomized, single-blind, prospective study (1:1, 2 group randomization) comparing a group of patients who benefited from the use of the virtual reality headset to a group of patients who received standard care during balloon insertion. Two groups of patients will be formed: a "standard care" group and a "standard care + virtual reality" group.

The study will take place at the Saint-Etienne University Hospital Center in the gynecology-obstetrics department.

The principal objective is to evaluate the effectiveness of the use of a virtual reality helmet on the reduction of pain during the insertion of an intra-cervical balloon for childbirth induction versus the use of standard care.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
60
Inclusion Criteria
  • Any pregnant woman presenting to the Gynecology-Obstetrics Department of the Saint-Etienne University Hospital for an induction by Cook's balloon.
  • Patients affiliated or entitled to a social security system
  • Patients having given their agreement to participate and after signing the consent form
Exclusion Criteria
  • Woman refusing to participate in the study (lack of consent)
  • Non French-speaking woman (impossibility of carrying out a good quality interview of the pregnant woman)
  • Women suffering from blindness, deafness or epilepsy against the use of the virtual reality helmet.
  • Participation in another interventional study.
  • Patient under guardianship or curatorship
  • Patient subject to a legal protection measure or unable to express their consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
maximum pain felt during balloon placementDay: 0

Measurement of the maximum pain experienced during the placement of the intra-cervical balloon using a numerical scale from 0 to 10: 0 = no pain, 10 = maximum pain.

Secondary Outcome Measures
NameTimeMethod
Nociception Level Index (NOL™) during balloon placementDay: 0

Measured Nociception Level Index (NOL ™) calculated by the PMD200 Pain Monitor™.

Nociception Level Index is numerical index from 0 to 100. (\>25 = pain)

patient's satisfaction with the use of the virtual reality headset.Day: 0

patient's satisfaction is evaluated by Likert scale: Completely satisfied/ Satisfied/ Neutral/ Not satisfied/ Not at all satisfied

Anxiety felt during balloon placementDay: 0

Anxiety felt during balloon placement measured by a numerical scale from 0 to 10 : 0 = no anxiety - 10 = maximum anxiety.

difficulty of balloon placement by the midwife during induction of laborDay: 0

Difficulty of balloon placement by the midwife is measured by questionary classified as very easy / easy / ni easy ni difficult / difficult / very difficult

average pain felt during balloon placementDay: 0

Average pain felt during balloon placement measured by a numerical scale from 0 to 10. (0 no pain - 10 maximum pain).

midwife's satisfaction with the use of the virtual reality headset.Day: 0

midwife's satisfaction is evaluated by Likert scale: Completely satisfied/ Satisfied/ Neutral/ Not satisfied/ Not at all satisfied

tolerance of the virtual reality helmet by the patient.Day: 0

Tolerance is a composite outcome : nausea (YES/NO), dizziness (YES/NO), premature stopping (YES/NO)

Trial Locations

Locations (1)

CHU de Saint-Etienne

🇫🇷

Saint-Étienne, France

CHU de Saint-Etienne
🇫🇷Saint-Étienne, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.